NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY

MLA

Carlen Yuen, et al. Ncmp-18. Neurotoxicity as a Potential Surrogate Marker for Therapeutic Response with Commercial Anti-Cd19 Car T-Cell Therapy. Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....66807aa258ad894359677cf95757efe0&authtype=sso&custid=ns315887.

APA

Carlen Yuen, Tao Xie, James A. Mastrianni, Anthony T. Reder, Thomas Kelly, Betty Soliven, Deric M. Park, Satyajit Kosuri, Kourosh Rezania, Michael R. Bishop, Andrew S. Artz, Shasha Wu, Peter A. Riedell, Wesley Klejch, & Saad Ali. (2020). Ncmp-18. Neurotoxicity as a Potential Surrogate Marker for Therapeutic Response with Commercial Anti-Cd19 Car T-Cell Therapy.

Chicago

Carlen Yuen, Tao Xie, James A. Mastrianni, Anthony T. Reder, Thomas Kelly, Betty Soliven, Deric M. Park, et al. 2020. “Ncmp-18. Neurotoxicity as a Potential Surrogate Marker for Therapeutic Response with Commercial Anti-Cd19 Car T-Cell Therapy,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....66807aa258ad894359677cf95757efe0&authtype=sso&custid=ns315887.